Cancer treatment with Go 6976
US6303646A · kind A · utility
Inventors
Key dates
| Filing date | Aug 9, 1999 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | Aug 9, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A chemotheraputic cancer treatment in which Go6976 or one of its derivatives is administered to a mammal for the treatment of the cancer. The Go6976 or its derivative is directed to PKC .alpha. activity. Experiments have shown Go6976 to be effective for the treatment of breast cancer, leukemia, lung cancer, bone cancer and skin cancer. These treatments may be accomplished utilizing Go6976 or its derivatives alone or in combination with other prior art chemotherapy agents or in combination with radiation therapy. In a preferred embodiment Go6976 is used for the treatment of cancer as a preventative drug by preventing cancer cell formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.